NANOCHON, INC.

Profile

Company Names

NANOCHON, INC.

Addresses

1317 SHEPHERD ST NW, UNIT D, WASHINGTON, DC 20011

1317 SHEPHERD STREET, NW, UNIT D, WASHINGTON, DC 20011

Phone Numbers

7039946099

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$9,579,592.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-12-24 
$3,582,315.00 
$4,223,097.00 
$640,782.00 
Equity 
2
2023-08-15 
$3,991,279.00 
$6,000,000.00 
$2,008,721.00 
Equity 
1
2021-09-16 
$2,005,998.00 
$2,500,000.00 
$494,002.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NATHAN 
 
CASTRO 
EXECUTIVE OFFICER, DIRECTOR
NANOCHON, INC.
SEAN 
 
CHURCHILL 
DIRECTOR
SENTIAR, INC.   |  CULTIVATE(MD) CAPITAL OPPORTUNITY FUND, L.P.   |  PRANA THORACIC, INC.   |  NANOCHON, INC.
ROBERT 
 
CREEDEN 
DIRECTOR
LIFE IMAGE, INC.   |  LIFE IMAGE INC.   |  BRIGHTSPEC, INC.   |  SLATE BIO, INC.   |  NANOCHON, INC.
BENJAMIN 
 
HOLMES 
EXECUTIVE OFFICER, DIRECTOR
SHAPEWAYS, INC.   |  SUPER EVIL MEGA CORP.   |  NANOCHON, INC.
GREG 
 
HORNER 
DIRECTOR
TAU SCIENCE CORP   |  NANOCHON, INC.
KURT 
 
JACOBUS 
DIRECTOR
ADDITIVE DEVICE, INC.   |  RESTOR3D, INC.   |  FRAUDSCOPE INC.   |  NANOCHON, INC.   |  EARLITEC DIAGNOSTICS, INC.   |  SYNAPTRIX, INC.   |  HUXLEY MEDICAL, INC.   |  CURVAFIX, INC.
NICK 
 
PACHUDA 
DIRECTOR
NANOCHON, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-12-24 
2024-05-15
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-15 
2023-08-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-15 
2021-10-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#